Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series

Clinical Rheumatology

Volumn 33, Issue 1, 2014, Pages 49-55

  Cipriani, Paola ^a   Ruscitti, Piero ^a   Carubbi, Francesco ^a   Pantano, Ilenia ^a   Liakouli, Vasiliki ^a   Berardicurti, Onorina ^a   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Adult onset Still's disease; First line therapy; Interleukin 6; Tocilizumab

Indexed keywords

METHOTREXATE; PREDNISONE; TOCILIZUMAB;

ADULT; ADULT ONSET STILL DISEASE; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERTRANSAMINASEMIA; INJECTION SITE REACTION; MEGALOBLASTIC ANEMIA; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; BIOLOGICAL PRODUCTS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; REMISSION INDUCTION; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 84900218013     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2381-5     Document Type: Article

References (38)

1. Bywaters EG (1971) Still's disease in the adult. Ann Rheum Dis 30: 121-133
2. Cabane J, Michon A, Ziza JM, Bourgeois P, Bletry O, Godeau P, Kahn MF (1990) Comparison of long-term evolution of adult onset and juvenile onset Still's disease, both followed up for more than10 years. Ann Rheum Dis 49:283-285
3. Kong XD, XuD, ZhangW, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases. Clin Rheumatol 29:1015-1019
4. Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65(5):564-572
5. Choi JH, Suh CH, Lee YM, Kim SS, Nahm DH, Park HS (2003) Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30:2422-2427
6. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424-430
7. Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, Rozenberg S, Piette JC, Bourgeois (2002) Proposal for a new set of classification criteria for adult-onset still disease. Med (Baltimore) 8: 194-200
8. Fautrel B (2008) Adult-onset Still disease. Best Pract Res 22(5):773-792
9. Pouchot J, Arlet JB (2012) Biological treatment in adult-onset Still's disease. Best Pract Res Clin Rheumatol 26:477-487. doi:10.1016/j. berh.2012.07.002
10. Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME (2002) Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46:1171-1176
11. Fautrel B, Sibilia J, Mariette X, Combe B, the Club Rheumatisms et Inflammation (2005) Tumour necrosis factor-blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64:262-266
12. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA (2005) Rapid responses to anakinra in patients with refractory adult onset Still's disease. Arthritis Rheum 52:1794-1803
13. Lequerre T, Quartier P, Rosellini D, Alaoui F, De BandtM,Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job- Deslandre C, Fautrel B, Le Loët X, Sibilia J, Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI) (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease: preliminary experience in France. Ann Rheum Dis 67:302-308
14. de Boysson H, Février J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence. Clin Rheumatol 32:141-147. doi:10.1007/s10067-012-2105-2, Epub 2012 Oct 30
15. Nakahara H, Mima T, Yoshio-Hoshino N, MatsushitaM, Hashimoto J, Nishimoto N (2009) Acase report of a patientwith refractory adultonset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 19:69-72
16. Matsumoto K, Nagashima T, Takatori S, Kawahara Y, Yagi M, Iwamoto M, Okazaki H, Minota S (2009) Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 28:485-487
17. Sumida K, Ubara Y, Hoshino J, Suwabe T, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Sawa N, Takemoto F, Takaichi K (2010) Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 29:1191-1194
18. Sabnis GR, Gokhale YA, Kulkarni UP (2011) Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis-efficacy of interleukin-6 blockade and review of the literature. Semin Arthritis Rheum 40:365-368
19. Puéchal X, DeBandtM, Berthelot JM, BrebanM, Dubost JJ, Fain O, Kahn JE, Lequen L, Longy-Boursier M, Perdriger A, Schaeverbeke T, Toussirot E, Sibilia J, Club Rhumatismes Et Inflammation (2011) Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) 63:155-159
20. Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet 377:2138-2149
21. Yokota S, Imagawa T, MoriM,Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 371:998-1006
22. De Benedetti F, Brunner H, Ruperto N, CalvoN, Cuttica I,Malattia R et al (2010) Tocilizumab in patients with systemic juvenile idiopathic arthritis: efficacy data from the placebo controlled 12-week part of the phase 3 TENDER trial. Arthritis Rheum 62(suppl 10):1434
23. Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845-1850
24. Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, Horiuchi T, Minota S, Ishigatsubo Y, Ota T, Takei S, Soejima S, Inoue H, Koarada S, Tada Y, Nagasawa K (2012) Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Mod Rheumatol 22:712-719. doi:10.1007/s10165-011-0569-6
25. Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, van der Heijde D, Kishimoto T (2007) Study of active controlledmonotherapy used for rheumatoid arthritis, an IL- 6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x-ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 66:1162-1167
26. Inaba Y, Ozawa R, Imagawa T, Mori M, Hara Y, Miyamae T, Aoki C, Saito T, Yokota S (2011) Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment. Ann Rheum Dis 70:1693-1695
27. Strand V, Burmester GR, Ogale S, Devenport J, John A, Emery P (2012) Improvements in health-related quality of life after treatment with tocilizumabin patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study. Rheumatol (Oxford) 51(10):1860-1869
28. Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, Koeger AC,Meyer O, Guillevin L, Piette JC, Bourgeois P (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 28:322-329
29. Van Reeth C, Le Moel G, Lasne Y, Revenant MC, Agneray J, Kahn MF, Bourgeois P (1994) Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol 21:890-895
30. Akritidis N, Giannakakis I, Giouglis T (1996) Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol 23:201-202
31. Garnero P, Thompson E,Woodworth T, Smolen JS (2010) Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter doubleblind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone. Arthritis Rheumatol 62:33-43
32. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH (2012) Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Ophthalmology 119(8): 1569-1574
33. Rech J, Ronneberger M, Englbrecht M, Finzel S, Katzenbeisser J, Manger K, Manger B, Schett G (2011) Successful treatment of adultonset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis 70:390-392
34. Naniwa T, Ito R, Watanabe M, Hayami Y, Maeda S, Sasaki K, Iwagaitsu S (2010) Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. Clin Rheumatol. doi:10.1007/s10067-010-1562-8
35. Sakai R, Nagasawa H, Nishi E, Okuyama A, Takei H, Kurasawa T, Kondo T, Nishimura K, Shirai Y, Ito T, Kameda H, Takeuchi T, Amano K (2012) Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review. Clin Rheumatol 31:569-574
36. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, RavelliA, Schneider R,Woo P,Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R,GromA,WulffraatN, Zuber Z, Zulian F, Lovell D, Martini A, PRINTO, PRCSG (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 20(367):2385-2395
37. DougadosM, Kissel K, Sheeran T, Tak PP, Conaghan PG,Mola EM, Schett G, Amital H, Navarro-Sarabia F, Hou A, Bernasconi C, Huizinga TW(2013) Adding tocilizumab or switching to tocilizumab monotherapy inmethotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Ann Rheum Dis 72:43-50
38. Mavragani CP, Spyridakis EG, Koutsilieris M (2012) Adult-onset Still's disease: from pathophysiology to targeted therapies. Int J Inflamm 2012:879020. doi:10.1155/2012/879020